The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata ...

Retrieved on: 2021-12-06 12:01:41

Tags for this article:

Click the tags to see associated articles and topics

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata .... View article details on hiswai:

Excerpt

The review period for CTI BioPharma Corp. (NASDAQ: CTIC) myelofibrosis treatment was extended by three months. With omicron concerns raging, ...

Article found on: www.benzinga.com